Dr. Burkert Pieske and Dr. C. Michael Gibson Discuss: PARALLAX: Sacubitril/Valsartan versus Individualized RAAS Blockade in Patients with HFpEF September 1, 2020 2020 | Cardiology | ESC Tags: 2020, Cardiology, ESC Article Navigation Dr. Renato Lopes and Dr. C. Michael Gibson Discuss: BRACE CORONA: Continuing vs. Suspending ACE Inhibitors and ARBs in COVID-19 Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: RUC-4, a novel small molecule Platelet GPIIb/IIIa inhibitor designed for subcutaneous point of first contact STEMI treatment
